Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-6-8
pubmed:abstractText
In the absence of major contraindications, treatment guidelines recommend that, following a major traumatic event, all patients receive low molecular weight heparin (e.g. enoxaparin) as thromboprophylaxis for the prevention of deep vein thrombosis (DVT).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1198-581X
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
e215-26
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:17556789-Anticoagulants, pubmed-meshheading:17556789-Bayes Theorem, pubmed-meshheading:17556789-Canada, pubmed-meshheading:17556789-Cost-Benefit Analysis, pubmed-meshheading:17556789-Decision Support Techniques, pubmed-meshheading:17556789-Drug Costs, pubmed-meshheading:17556789-Enoxaparin, pubmed-meshheading:17556789-Hemorrhage, pubmed-meshheading:17556789-Heparin, pubmed-meshheading:17556789-Humans, pubmed-meshheading:17556789-Insurance, Pharmaceutical Services, pubmed-meshheading:17556789-Models, Economic, pubmed-meshheading:17556789-Practice Guidelines as Topic, pubmed-meshheading:17556789-Probability, pubmed-meshheading:17556789-Pulmonary Embolism, pubmed-meshheading:17556789-Trauma Severity Indices, pubmed-meshheading:17556789-Treatment Outcome, pubmed-meshheading:17556789-Venous Thrombosis, pubmed-meshheading:17556789-Wounds and Injuries
pubmed:year
2007
pubmed:articleTitle
A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.
pubmed:affiliation
Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada. llynd@interchange.ubc.ca
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't